LNTH
Lantheus Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -9.6% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 130 | +6 | 56.22M | $5.58B | +14 | −7 |
| Q1 2026 | 126 | +6 | 62.19M | $3.90B | +10 | −5 |
| Q4 2025 | 120 | -2 | 60.97M | $3.47B | +2 | −3 |
| Q3 2025 | 20 | +2 | 33.16M | $1.70B | +2 | −1 |
| Q2 2025 | 16 | -2 | 29.15M | $2.39B | +1 | −3 |
| Q1 2025 | 15 | 0 | 7.80M | $761.04M | — | — |
| Q4 2024 | 15 | 0 | 6.76M | $604.90M | +2 | −2 |
| Q3 2024 | 14 | 0 | 4.84M | $531.32M | +1 | −1 |
| Q2 2024 | 14 | — | 5.72M | $459.02M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 2.64M | — | $236.15M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 2.64M | — | $236.15M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.68M | 0.0% | $150.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.68M | 0.0% | $150.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.10M | -12.1% | $98.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.10M | -12.1% | $98.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Norges Bank ✦ (pasivo) | 292.75K | -41.8% | $26.19M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 223.81K | Nuevo | $20.02M | 0.0% | New | 1 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 153.45K | 0.0% | $13.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 149.41K | Nuevo | $13.37M | 0.0% | New | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 149.41K | Nuevo | $13.37M | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 121.25K | -25.8% | $10.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 121.25K | -25.8% | $10.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 121.25K | -25.8% | $10.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 109.68K | +55.7% | $9.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 109.10K | -69.9% | $9.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 97.67K | -62.0% | $8.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 97.67K | -62.0% | $8.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Marshall Wace ✦ | 97.67K | -62.0% | $8.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 36.39K | -64.9% | $3.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 23.88K | -29.5% | $2.14M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 23.88K | -29.5% | $2.14M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 12.90K | +4.8% | $1.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Millennium Management ✦ | 4.83K | -97.8% | $432,002 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Millennium Management ✦ | 4.83K | -97.8% | $432,002 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Wellington Management | $20.02M | 0.0% |
| Citadel Advisors | $13.37M | 0.0% |
| Citadel Advisors | $13.37M | 0.0% |
Posición cerrada
| Point72 Asset Management | $1.91M | era 0.0% |
| D. E. Shaw & Co. | $251,437 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 401 tenedores, 70.59M acciones, $5.23B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.